Efficacy of induction chemotherapy combined with concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma

Chinese Journal of Clinical Oncology

Volumn 39, Issue 11, 2012, Pages 788-791

  Huang, Shengwu ^a   Deng, Ganque ^a   Huang, Guangyou ^a   Li, Yumei ^a   Meng, Yiliang ^a   Chen, Jianxian ^a  

^a Guangxi Baise People's Hospital   (China)

Author keywords

Concurrent chemoradiotherapy; Induction chemotherapy; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; UNSPECIFIED SIDE EFFECT;

EID: 84865336124     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2012.11.009     Document Type: Article

References (15)

1. Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment[J]. Semin Oncol, 1994, 21(3), 382-397. (Pubitemid 24191598)
2. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma[J]. Lancet, 1997, 350(9084): 1087-1091. (Pubitemid 27437868)
3. Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the reladonship of race and national origin to the histology of nasopharyngeal carcinoma[J]. Cancer, 1998, 83(3): 582-588. (Pubitemid 28354516)
4. Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone[J]. Int J Radiat Oncol Biol Phys, 2005, 62(3): 672-679. (Pubitemid 40779753)
5. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience[J]. Int J Radiat Oncol Biol Phys, 2005, 61(4): 1107-1116. (Pubitemid 40340904)
6. Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2003, 56(4): 1046-1054. (Pubitemid 36794036)
7. Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2002, 53(3): 638-647. (Pubitemid 34626502)
8. Langendijk JA, Leemans CR, Buter J, et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature[J]. J Clin Oncol, 2004, 22(22): 4604-4612. (Pubitemid 41185128)
9. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients[J]. Int J Radiat Oncol Biol Phys, 2006, 64(1): 47-56. (Pubitemid 41831208)
10. Chua DT, Ma J, Sham JS, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials[J]. J Clin Oncol, 2005, 23(6): 1118-1124. (Pubitemid 46202267)
11. Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety[J]. J Clin Oncol, 2005, 23(27): 6730-6738. (Pubitemid 46190268)
12. Lee AW, Tung SY, Chan AT, et al. Preliminary results of a randomized study (NPG-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2006, 66(1): 142-151. (Pubitemid 44175659)
13. Sanguineti G, Bossi P, Pou A, Licitra L. Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma[J]. Clin Oncol (R Coll Radiol), 2003, 15(8): 451-460. (Pubitemid 37455741)
14. Yau TK, Lee AW, Wong DH, et al. Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes[J]. Int J Radiat Oncol Biol Phys, 2006, 66(4): 1004-1010. (Pubitemid 44633506)
15. Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, et al. Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial[J]. Eur J Cancer, 2007, 43(9): 1399-1406. (Pubitemid 46874069)